Drug therapies improve delirium outcomes in non-ICU adult patients
Evidence regarding the efficacy of drug therapies for improving delirium outcomes in non-ICU adult patients is mixed, with major systematic reviews finding little clear benefit for many standard pharmacological agents, despite isolated positive trials for specific medications.
The claim specifically addresses drug therapies improving delirium outcomes in non-ICU adult patients. The retrieved literature (such as Cochrane reviews by Siddiqi et al. 2016) indicates that while multicomponent non-pharmacological interventions have strong backing, the evidence for pharmacological interventions (like cholinesterase inhibitors, antipsychotics, or melatonin) preventing or treating delirium is largely uncertain, mixed, or lacking clear benefit, though some network meta-analyses point to specific drugs showing lower incidence rates. Thus, the verdict is CONTESTED.
The evidence we hold leans evenly split
How this was weighed
official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x
- Interventions for preventing delirium in hospitalised non-IC · peer-reviewed · supports · weight 2 · 2016
- Association of Delirium Response and Safety of Pharmacologic · peer-reviewed · supports · weight 1.6 · 2019
- Interventions for preventing delirium in hospitalised non-IC · peer-reviewed · refutes · weight 2 · 2016
- Pharmacological interventions for the treatment of delirium · peer-reviewed · refutes · weight 1.6 · 2019
Najma Siddiqi, Jennifer Harrison, Andrew Clegg, Elizabeth Teale, John Young, J. Taylor, Samantha A Simpkins. Interventions for preventing delirium in hospitalised non-ICU patients. 2016. https://doi.org/10.1002/14651858.cd005563.pub3
Some specific pharmacological agents, such as atypical antipsychotics (e.g., olanzapine) or ramelteon, showed reductions in delirium incidence in certain inpatient settings.
Najma Siddiqi, Jennifer Harrison, Andrew Clegg, Elizabeth Teale, John Young, J. Taylor, Samantha A Simpkins. Interventions for preventing delirium in hospitalised non-ICU patients. 2016. https://doi.org/10.1002/14651858.cd005563.pub3
Broad systematic reviews find no clear evidence that routine drugs like cholinesterase inhibitors, typical antipsychotics, or melatonin effectively prevent delirium in non-ICU patients.
See more details
Yi‐Cheng Wu, Ping‐Tao Tseng, Yu‐Kang Tu, Chung‐Yao Hsu, Chih‐Sung Liang, Ta‐Chuan Yeh, Tien‐Yu Chen, Che‐Sheng Chu, Yutaka Matsuoka, Brendon Stubbs, André F. Carvalho, Saho Wada, Pao‐Yen Lin, Yen‐Wen Chen, Kuan‐Pin Su. Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of Delirium. 2019. https://doi.org/10.1001/jamapsychiatry.2018.4365
Network meta-analyses demonstrate that certain pharmacological interventions can lower delirium occurrence rates or provide treatment response compared to placebo.
Lisa Burry, Brian Hutton, David Williamson, Sangeeta Mehta, Neill K. J. Adhikari, Wei Cheng, E. Wesley Ely, Ingrid Egerod, Dean Fergusson, Louise Rose. Pharmacological interventions for the treatment of delirium in critically ill adults. 2019. https://doi.org/10.1002/14651858.cd011749.pub2
Comprehensive reviews indicate that pharmacological interventions often lack robust evidence of efficacy for improving key patient-centered outcomes in delirium.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt